151 related articles for article (PubMed ID: 25006815)
1. Omega-3 Fatty acids and gestational length in a high-risk psychiatric population due to psychiatric morbidity and medication exposure during pregnancy.
Freeman MP; Cohen LS; McInerney K
J Clin Psychopharmacol; 2014 Oct; 34(5):627-32. PubMed ID: 25006815
[TBL] [Abstract][Full Text] [Related]
2. The effect of omega-3 supplementation on pregnancy outcomes by smoking status.
Kuper SG; Abramovici AR; Jauk VC; Harper LM; Biggio JR; Tita AT
Am J Obstet Gynecol; 2017 Oct; 217(4):476.e1-476.e6. PubMed ID: 28549983
[TBL] [Abstract][Full Text] [Related]
3. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
Lewis AJ; Galbally M; Opie G; Buist A
Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
[TBL] [Abstract][Full Text] [Related]
4. Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population.
Hironaka M; Kotani T; Sumigama S; Tsuda H; Mano Y; Hayakawa H; Tanaka S; Ozaki N; Tamakoshi K; Kikkawa F
J Obstet Gynaecol Res; 2011 Oct; 37(10):1283-9. PubMed ID: 21535304
[TBL] [Abstract][Full Text] [Related]
5. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J
Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283
[TBL] [Abstract][Full Text] [Related]
6. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development.
Larsen AD
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial.
Simmonds LA; Sullivan TR; Skubisz M; Middleton PF; Best KP; Yelland LN; Quinlivan J; Zhou SJ; Liu G; McPhee AJ; Gibson RA; Makrides M
BJOG; 2020 Jul; 127(8):975-981. PubMed ID: 32034969
[TBL] [Abstract][Full Text] [Related]
8. Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses.
Sutter-Dallay AL; Bales M; Pambrun E; Glangeaud-Freudenthal NM; Wisner KL; Verdoux H
J Clin Psychiatry; 2015 Jul; 76(7):967-73. PubMed ID: 25844580
[TBL] [Abstract][Full Text] [Related]
9. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
Kowalska-Kańka A; Maciejewski T; Niemiec KT
Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study.
Frayne J; Nguyen T; Hauck Y; Liira H; Keelan JA
J Clin Psychopharmacol; 2018 Dec; 38(6):563-569. PubMed ID: 30346334
[TBL] [Abstract][Full Text] [Related]
11. The use of omega 3 on pregnancy outcomes: a single-center study.
Fereidooni B; Jenabi E
J Pak Med Assoc; 2014 Dec; 64(12):1363-5. PubMed ID: 25842578
[TBL] [Abstract][Full Text] [Related]
12. Effects of omega-3 fatty acids in prevention of early preterm delivery: a systematic review and meta-analysis of randomized studies.
Kar S; Wong M; Rogozinska E; Thangaratinam S
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():40-46. PubMed ID: 26773247
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects.
Bodén R; Lundgren M; Brandt L; Reutfors J; Kieler H
Arch Gen Psychiatry; 2012 Jul; 69(7):715-21. PubMed ID: 22752236
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
[TBL] [Abstract][Full Text] [Related]
15. Maternal fish consumption, fetal growth and the risks of neonatal complications: the Generation R Study.
Heppe DH; Steegers EA; Timmermans S; Breeijen Hd; Tiemeier H; Hofman A; Jaddoe VW
Br J Nutr; 2011 Mar; 105(6):938-49. PubMed ID: 21266095
[TBL] [Abstract][Full Text] [Related]
16. Association of maternal omega-6 fatty acid intake with infant birth outcomes: Korean Mothers and Children's Environmental Health (MOCEH).
Lee E; Kim H; Kim H; Ha EH; Chang N
Nutr J; 2018 Apr; 17(1):47. PubMed ID: 29679982
[TBL] [Abstract][Full Text] [Related]
17. Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy.
Freeman MP; Sosinsky AZ; Goez-Mogollon L; Savella GM; Moustafa D; Viguera AC; Cohen LS
Psychosomatics; 2018; 59(2):125-134. PubMed ID: 29078988
[TBL] [Abstract][Full Text] [Related]
18. Obstetrical and neonatal outcomes in women following gastric bypass: a Danish national cohort study.
Berlac JF; Skovlund CW; Lidegaard O
Acta Obstet Gynecol Scand; 2014 May; 93(5):447-53. PubMed ID: 24592873
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.
van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
Drug Alcohol Depend; 2010 Jun; 109(1-3):243-7. PubMed ID: 20171023
[TBL] [Abstract][Full Text] [Related]
20. Effect of low lead exposure on gestational age, birth weight and premature rupture of the membrane.
Mirghani Z
J Pak Med Assoc; 2010 Dec; 60(12):1027-30. PubMed ID: 21381557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
